Biological and clinical relevance of anti-prothrombin antibodies

Annals of the New York Academy of Sciences

Volumn 1109, Issue , 2007, Pages 503-510

  Ghirardello, Anna ^a   Bizzaro, Nicola ^b,f   Zampieri, Sandra ^a   Iaccarino, Luca ^a   Bassi, Nicola ^a   Tozzoli, Renato ^c   Ruffatti, Amelia ^a   Villalta, Danilo ^d   Tonutti, Elio ^e   Doria, Andrea ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b Ospedale Civile di Tolmezzo   (Italy)

^c Hospital of Latisana   (Italy)

^d S Maria Degli Angeli Regional Hospital   (Italy)

^e SANTA MARIA DELLA MISERICORDIA UNIVERSITY HOSPITAL   (Italy)

^f Civil Hospital   (Italy)

Author keywords

Anti prothrombin antibody; Detection methods; Predictive value; Prothrombin; Systemic lupus erythematosus

Indexed keywords

BETA2 GLYCOPROTEIN 1; CARDIOLIPIN ANTIBODY; LUPUS ANTICOAGULANT; PROTHROMBIN; PROTHROMBIN ANTIBODY; ANTIBODY;

ANTIBODY DETECTION; ANTIPHOSPHOLIPID SYNDROME; CONFERENCE PAPER; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; HUMAN; IMMUNOASSAY; PREDICTION; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOSIS; ARTICLE; BLOOD; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOLOGY;

ANTIBODIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; PROTHROMBIN;

EID: 34848894605     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1398.056     Document Type: Conference Paper

References (39)

1. ROUBEY, R.A.S. 1994. Autoantibodies to phospholipid-binding plasma proteins: a new view of lupus anticoagulants and other "antiphospholipid" antibodies. Blood 84: 2854-2867.
2. GALLI, M., P. COMFURIUS, C. MAASSEN, et al. 1990. Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor. Lancet 335: 1544-1547.
3. MCNEIL, H.P., R.J. SIMPSON, C.N. CHESTERMAN, et al. 1990. Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta2-glycoprotein I (apolipoprotein H). Proc. Natl. Acad. Sci. 87: 4120-4124.
4. BEVERS, E.M., M. GALLI, T. BARBUI, et al. 1991. Lupus anticoagulant IgG's (LA) are not directed to phospholipids only, but to a complex of lipid-bound human prothrombin. Thromb. Haemost. 66: 629-632.
5. LOELIGER, A. 1959. Prothrombin as a co-factor of the circulating anticoagulant in systemic lupus erythematosus? Thromb. Diath. Haemorrh. 3: 237-256.
6. BAJAJ, S., S. RAPAPORT D. FIERER, et al. 1983.Amechanism for the hypoprothrombinemia of the acquired hypoprothrombinemia-lupus anticoagulant syndrome. Blood 61: 684-692.
7. FLECK, R., S. RAPAPORT & L. RAO. 1988. Antiprothrombin antibodies and the lupus anticoagulant. Blood 72: 512-519.
8. PERMPIKUL, P., L. RAO & S. RAPAPORT. 1994. Functional and binding studies of the roles of prothrombin and β2-glycoprotein I in the expression of lupus anticoagulant activity. Blood 83: 2878-2892.
9. SIMMELINK, M.J.A., D.A. HORBACH, R.H.W.M. DERKSEN, et al. 2001. Complexes of anti-prothrombin antibodies and prothrombin cause lupus anticoagulant activity by competing with the binding of clotting factors for catalytic phospholipid surfaces. Br. J. Haematol. 113: 621-629.
10. GALLI, M., G. BERETTA, M. DALDOSSI, et al. 1997. Different anticoagulant and immunological properties of anti-prothrombin antibodies in patients with antiphospholipid antibodies. Thromb. Haemost. 77: 486-491.
11. HORBACH, D., E. VAN OORT, R. DERKSEN, et al. 1998. The contribution of antiprothrombin antibodies to lupus anticoagulant activity: discrimination between functional and non-functional anti-prothrombin antibodies. Thromb. Haemost. 79: 790-795.
12. FIELD, S.L., C.N. CHESTERMAN & P.J. HOGG. 2000. Dependence on prothrombin for inhibition of activated protein C activity by lupus antibodies. Thromb. Haemost. 84: 1132-1133.
13. NOJIMA, J., H. KURATSUNE, E. SUEHISA, et al. 2002. Acquired activated protein C resistance is associated with the co-existence of anti-prothrombin antibodies and lupus anticoagulant activity in patients with systemic lupus erythematosus. Br. J. Haematol. 118: 577-583.
14. GALLI, M., G.M. WILLEMS, J. ROSING, et al. 2005. Anti-prothrombin IgG from patients anti-phospholipid antibodies inhibits the inactivation of factor Va by activated protein C. Br. J. Haematol. 129: 240-247.
15. HAJ-YAHIA, S., Y. SHERER, M. BLANK, et al. 2003. Anti-prothrombin antibodies cause thrombosis in a novel qualitative ex-vivo animal model. Lupus 12: 364-369.
16. ZHAO, Y., R. RUMOLD, M. ZHU, et al. 1999. An IgG antiprothrombin antibody enhances prothrombin binding to damaged endothelial cells and shortens plasma coagulation times. Arthritis Rheum. 42: 2132-2138.
17. VEGA-OSTERTAG, M., X. LIU, H. KWAN-KI, et al. 2006. A human monoclonal antiprothrombin antibody is thrombogenic in vivo and upregulates expression of tissue factor and E-selectin on endothelial cells. Br. J. Haematol. 135: 214-219.
18. TINCANI, A., G. MOROZZI, D. VILLALTA, et al. 2007. Antiprothrombin antibodies: comparative analysis of home made and commercial methods. A collaborative work of the FIRMA group. Clin. Exp. Rheumatol. In press.
19. ARVIEUX, J., L. DARNIGE, C. CARON, et al. 1995. Development of an ELISA for autoantibodies to prothrombin showing their prevalence in patients with lupus anticoagulants. Thromb. Haemost. 74: 1120-1125.
20. DONOHOE, S., I.J. MACKIE, D. ISENBERG, et al. 2001. Anti-prothrombin antibodies: assay conditions and clinical associations in the anti-phospholipid syndrome. Br. J. Haematol. 113: 544-549.
21. ATSUMI, T., M. IEKO, M.L. BERTOLACCINI, et al. 2000. Association of autoantibodies against the phosphatidylserine- prothrombin complex with manifestations of the antiphospholipid syndrome and with the presence of lupus anticoagulant. Arthritis Rheum. 43: 1982-1993.
22. HORITA, T., K. ICHIKAWA, S. YASUDA, et al. 2000. IgM phosphatidylserine dependent monoclonal antibody from a patient with antiphospholipid syndrome [abstract]. J. Autoimmun. 15: A20, PD7.
23. BERTOLACCINI, M.L., T. ATSUMI, T. KOIKE, et al. 2005. Antiprothrombin antibodies detected in two different assay systems. Prevalence ancd clinical significance in systemic lupus erythematosus. Thromb. Haemost. 93: 289-297.
24. TSUTSUMI, A., T. HAYASHI, Y. CHINO, et al. 2006. Significance of antiprothrombin antibodies in patients with systemic lupus erythematosus: clinical evaluation of the antiprothrombin assay and the antiphosphatidylserine/prothrombin assay, and comparison with other antiphospholipid antibody assays. Mod. Rheumatol. 16: 158-164.
25. ATSUMI, T. & T. KOIKE. 2002. Clinical relevance of antiprothrombin antibodies. Autoimmunity Rev. 1: 49-53.
26. VON LANDENBERG, P., T. MATTHIAS, J. ZAECH, et al. 2003. Antiprothrombin antibodies are associated with pregnancy loss in patients with the antiphospholipid syndrome. Am. J. Reprod. Immunol. 49: 51-56.
27. GALLI, M. 2004. Antiphospholipid syndrome: association between laboratory tests and clinical practice. Pathophysiol. Haemost. Thromb. 33: 249-255.
28. NOJIMA, J., H. KURATSUNE, E. SUEHISA, et al. 2001. Anti-prothrombin antibodies combined with lupus anticoagulant activity is an essential risk factor for venous thromboembolism in patients with systemic lupus erythematosus. Br. J. Haematol. 114: 647-654.
29. PASQUIER, E., J. AMIRAL, L. DE SAINT MARTIN, et al. 2001.Across sectional study of antiphospholipid-protein antibodies in patients with venous thromboembolism. Thromb. Haemost. 86: 538-542.
30. MUÑOZ-RODRIGUEZ, F.J., J.C. REVERTER, J. FONT, et al. 2000. Prevalence and clinical significance of anti-prothrombin antibodies in patients with systemic lupus erythematosus or with primary anti-phospholipid syndrome. Haematologica 85: 632-637.
31. PALOSUO, T., J. VIRTAMO, J. HAUKKA, et al. 1997. High antibody levels to prothrombin imply a risk of deep venous thrombosis and pulmonary embolism in middle-aged men. Thromb. Haemost. 78: 1178-1182.
32. ISHIKURA, K., H. WADA, Y. KAMIKURA, et al. 2004. High prevalence of antiprothrombin antibody in patients with deep vein thrombosis. Am. J. Hematol. 76: 338-342.
33. NOJIMA, J., H. KURATSUNE, E. SUEHISA, et al. 2001. Association between the prevalence of antibodies to B2-glycoprotein I, prothrombin, protein C, protein S, and annexin V in patients with systemic lupus erythematosus and thrombotic and thrombocytopenic complications. Clin. Chem. 47: 1008-1015.
34. FORASTIERO, R., M.E. MARTINUZZO, Y. ADAMCZUK, et al. 1999. Occurrence of antiprothrombin and anti-beta2-glycoprotein I antibodies in patients with a history of thrombosis. J. Lab. Clin. Med. 134: 610-615.
35. BIZZARO, N., E. TONUTTI, D. VILLALTA, et al. 2005. Prevalence and clinical correlation of anti-phospholipid-binding protein antibodies in anticardiolipin-negative patients with systemic lupus erythematosus and women with unexplained recurrent miscarriages. Arch. Pathol. Lab. Med. 129: 61-68.
36. HORBACK, D.A., E. VAN OORT, R.C. DONDERS, et al. 1996. Lupus anticoagulant is the strongest risk factor for both venous and arterial thrombosis in patients with systemic lupus erythematosus. Comparison between different assays for the detection of antiphospholipid antibodies. Thromb. Haemost. 76: 916-924.
37. PENGO, V., A. BIASIOLO, T. BROCCO, et al. 1996. Autoantibodies to phospholipidbinding plasma proteins in patients with thrombosis and phospholipid-reactive antibodies. Thromb. Haemost. 75: 721-724.
38. SWADZBA, J., L.S. DE CLERCK, W.L. STEVENS, et al. 1997. Anti-cardiolipin, antibeta(2)-glycoprotein I, antiprothrombin antibodies, and lupus anticoagulant in patients with systemic lupus erythematosus with a history of thrombosis. J. Rheumatol. 24: 1710-1715.
39. GALLI, M., D. LUCIANI, G. BERTOLINI, et al. 2003. Anti-B2-glycoprotein I, antiprothrombin antibodies, and the risk of thrombosis in the antiphospholipid syndrome. Blood 102: 2717-2723.